Sie sind auf Seite 1von 9

All key stakeholders of the pharmaceutical supply chain must

commit to the highest ethical standards and recognize the


Q1 importance of all applicable laws. %
Strongly Agree 29
Agree 25
Neutral 22
Disagree 11
Strongly Disagree 13

Based on service, the market has been segmented into logistics


Q2 and procedures. %
Strongly Agree 36
Agree 22
Neutral 19
Disagree 16
Strongly Disagree 7

The demand for pharmaceutical logistics is growing in India on


account of the increasing sales of generic drugs, as well as
Q3 reforms in the healthcare sector favouring generics. %
Strongly Agree 39
Agree 28
Neutral 15
Disagree 14
Strongly Disagree 4
One trend to be observed within pharma logistics is the move
Q4 toward regional logistics organizations. %
Strongly Agree 44
Agree 27
Neutral 11
Disagree 9
Strongly Disagree 9

Pharmaceutical products need to be kept at a particular


temperature throughout the transit period from manufacturer
Q5 to the end user. %
Strongly Agree 41
Agree 21
Neutral 18
Disagree 14
Strongly Disagree 6

The pharma retail segment is a very promising and upcoming


Q6 segment. %
Strongly Agree 48
Agree 22
Neutral 8
Disagree 12
Strongly Disagree 10
Healthcare logistics segment is highly specialized and extremely
Q7 diverse with their own share of problems and challenges. %
Strongly Agree 41
Agree 19
Neutral 16
Disagree 14
Strongly Disagree 10

There has been a paradigm shift in the supply chain process of


Q8 Indian pharmaceutical industry. %
Strongly Agree 42
Agree 25
Neutral 13
Disagree 12
Strongly Disagree 8

Operational performance could be directly linked to logistics


Q9 costs. %
Strongly Agree 36
Agree 12
Neutral 8
Disagree 29
Strongly Disagree 15
The industry has given importance to logistics by focusing on
supply chain and logistic level activities such as delivering the
product to the end-customer at the right time, right place, in a
Q10 secure mode and at a competitive operational cost. %
Strongly Agree 45
Agree 23
Neutral 12
Disagree 8
Strongly Disagree 12

The lifeblood of the pharmaceutical industry is new product


Q11 innovation and delivery. %
Strongly Agree 38
Agree 22
Neutral 5
Disagree 25
Strongly Disagree 10

The Indian logistics and transport industry has huge potential


Q12 growth prospects for local and foreign operators alike. %
Strongly Agree 40
Agree 15
Neutral 25
Disagree 15
Strongly Disagree 5
Logistics is a crucial part of the pharmaceutical industry as the
Q13 activities are highly time sensitive. %
Strongly Agree 30
Agree 25
Neutral 5
Disagree 28
Strongly Disagree 12

Today, pharmaceutical, biotechnology and life sciences sectors


have emerged as the new hot favourite with the service industry
and logistics companies are rushing in to offer tailor-made
Q14 solutions. %
Strongly Agree 45
Agree 25
Neutral 5
Disagree 10
Strongly Disagree 15

Pharmaceutical Logistics offers full visibility throughout the


Q15 supply chain. %
Strongly Agree 35
Agree 20
Neutral 10
Disagree 25
Strongly Disagree 10
Q16 The demand for pharmaceutical logistics is growing in India %
Strongly Agree 31
Agree 27
Neutral 9
Disagree 24
Strongly Disagree 9

Major companies in the market strive to offer cloud-based


Q17 supply chain solutions and secured supply chain functions %
Strongly Agree 43
Agree 27
Neutral 7
Disagree 13
Strongly Disagree 10

There is risk inherent to global pharmaceutical logistics. When


designing a logistics strategy any pharmaceutical company or
Q18 shipper should make certain they consider the risk factors: %
Strongly Agree 44
Agree 16
Neutral 18
Disagree 12
Strongly Disagree 10
Pharmaceutical companies must focus on developing a robust
risk management strategy in the mobile supply chain, ensuring
that effective controls and procedures are in place to proactively
Q19 mitigate the potential risks %
Strongly Agree 41
Agree 27
Neutral 12
Disagree 11
Strongly Disagree 9

The Indian logistics companies keep increasing their storage


network by building and hiring new storages in order to provide
efficient distribution logistics for pharmaceutical products and
Q20 for other products as well. %
Strongly Agree 43
Agree 27
Neutral 19
Disagree 6
Strongly Disagree 5

The global pharmaceutical market has nearly doubled over the


last 10 years, leading to an increase in sales volume and
Q21 penetration in developing nations throughout the world. %
Strongly Agree 42
Agree 9
Neutral 14
Disagree 25
Strongly Disagree 10

The most important supply chain factors in pharmaceutical


industry are inventory reduction and reduction of order cycle
Q22 time %
Strongly Agree 35
Agree 29
Neutral 12
Disagree 9
Strongly Disagree 15

One trend to be observed within pharma logistics is the move


Q23 toward regional logistics organization %
Strongly Agree 30
Agree 19
Neutral 21
Disagree 19
Strongly Disagree 11
Given the expectation that pharmaceutical companies, especially
Innovators, will increasingly offer additional services in the
medium-term future, logistics strategies will have to align closer
Q24 with manufacturing and commercial strategies %
Strongly Agree 53
Agree 35
Neutral 6
Disagree 4
Strongly Disagree 2

Organizations can misjudge the difficulty of executing transport.


Significant preparatory work is required to ensure that the
physical movement of the shipment is handled smoothly,
including planning the route, selecting an airline and the type of
Q25 temperature-controlled packaging. %
Strongly Agree 39
Agree 22
Neutral 16
Disagree 13
Strongly Disagree 10

Das könnte Ihnen auch gefallen